Oxidized low-density lipoprotein–dependent endothelial arginase II activation contributes to impaired nitric oxide signaling

S Ryoo, CA Lemmon, KG Soucy, G Gupta… - Circulation …, 2006 - Am Heart Assoc
Oxidized low-density lipoprotein (OxLDL) impairs NO signaling and endothelial function,
and contributes to the pathogenesis of atherosclerosis. Arginase reciprocally regulates NO …

Disorders of endothelium-dependent vascular reactions and of the arginase and NO-synthase pathways of L-arginine metabolism in arterial hypertension

VF Sahach, OV Baziliuk, AV Kotsiuruba… - … (Kiev, Ukraine: 1994), 2000 - europepmc.org
In normotensive rats (NTR) and spontaneously hypertensive rats (SHR) with high (subgroup
1) and low (subgroup 2) level of the systemic arterial pressure (SAP) we studied an activity …

Arginine/arginase no no no

GS Getz, CA Reardon - Arteriosclerosis, thrombosis, and vascular …, 2006 - Am Heart Assoc
Arginine is a semi-essential amino acid that plays a critical role in several metabolic
pathways. The best known of these is as the immediate precursor of urea in the liver and to a …

Arginine metabolism in vascular biology and disease

SM Morris - Vascular Medicine, 2005 - journals.sagepub.com
Arginine metabolism plays a major role in cardiovascular physiology and pathophysiology,
largely via nitric oxide (NO)-dependent processes. It is becoming increasingly apparent …

Genetic targeting of arginase-II in mouse prevents renal oxidative stress and inflammation in diet-induced obesity

J Huang, A Rajapakse, Y Xiong, JP Montani… - Frontiers in …, 2016 - frontiersin.org
Obesity is associated with development and progression of chronic kidney disease (CKD).
Recent evidence demonstrates that enhanced levels of the L-arginine: ureahydrolase …

Identification of macrophage arginase I as a new candidate gene of atherosclerosis resistance

D Teupser, R Burkhardt, W Wilfert, I Haffner… - … , and vascular biology, 2006 - Am Heart Assoc
Objective—Our laboratory has previously created 2 strains of rabbits with genetically
determined high-atherosclerotic response (HAR) and low-atherosclerotic response (LAR) …

Effect of arginase inhibition on ischemia-reperfusion injury in patients with coronary artery disease with and without diabetes mellitus

O Kövamees, A Shemyakin, J Pernow - PLoS One, 2014 - journals.plos.org
Background Arginase competes with nitric oxide synthase for their common substrate L-
arginine. Up-regulation of arginase in coronary artery disease (CAD) and diabetes mellitus …

Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats

JH Kim, LJ Bugaj, YJ Oh… - Journal of applied …, 2009 - journals.physiology.org
There is increasing evidence that upregulation of arginase contributes to impaired
endothelial function in aging. In this study, we demonstrate that arginase upregulation leads …

Arginase in the vascular endothelium: friend or foe?

R Lucas, D Fulton, RW Caldwell… - Frontiers in …, 2014 - frontiersin.org
This special issue, entitled “the role of arginase in endothelial dysfunction,” assembles
original contributions (1–4), as well as timely reviews (5–12) broadly related to the …

Arginase inhibition restores in vivo coronary microvascular function in type 2 diabetic rats

J Grönros, C Jung, JO Lundberg… - American Journal …, 2011 - journals.physiology.org
Nitric oxide (NO) is crucial for maintaining normal endothelial function and vascular integrity.
Increased arginase activity in diabetes might compete with NO synthase (NOS) for their …